NasdaqCM - Delayed Quote USD

Ekso Bionics Holdings, Inc. (EKSO)

1.4400 +0.0600 (+4.35%)
At close: 4:00 PM EDT
1.4400 0.00 (0.00%)
After hours: 6:48 PM EDT
Loading Chart for EKSO
DELL
  • Previous Close 1.3800
  • Open 1.3800
  • Bid 1.0200 x 200
  • Ask 1.7500 x 200
  • Day's Range 1.3500 - 1.4400
  • 52 Week Range 0.6200 - 3.1290
  • Volume 71,226
  • Avg. Volume 140,014
  • Market Cap (intraday) 26.171M
  • Beta (5Y Monthly) 1.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9700
  • Earnings Date Jul 25, 2024 - Jul 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.00

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

www.eksobionics.com

70

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EKSO

Performance Overview: EKSO

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EKSO
42.40%
S&P 500
10.00%

1-Year Return

EKSO
7.69%
S&P 500
27.22%

3-Year Return

EKSO
71.31%
S&P 500
27.58%

5-Year Return

EKSO
94.55%
S&P 500
86.59%

Compare To: EKSO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EKSO

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    25.08M

  • Enterprise Value

    23.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.15

  • Price/Book (mrq)

    1.78

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -79.48%

  • Return on Assets (ttm)

    -26.34%

  • Return on Equity (ttm)

    -80.59%

  • Revenue (ttm)

    17.91M

  • Net Income Avi to Common (ttm)

    -14.24M

  • Diluted EPS (ttm)

    -0.9700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.8M

  • Total Debt/Equity (mrq)

    48.69%

  • Levered Free Cash Flow (ttm)

    -6.44M

Research Analysis: EKSO

Company Insights: EKSO

Research Reports: EKSO

People Also Watch